AAP
VNRX icon

Arax Advisory Partners’s VolitionRx Ltd VNRX Stock Holding History

Arax Advisory Partners’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.5K Buy
+5,552
New +$13.4K ﹤0.01% 4455

Other funds holding VNRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Arax Advisory Partners's VNRX Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in VolitionRx Ltd (VNRX) in Q2 2026: 5,552 shares worth $7.5K. The stake represents ﹤0.01% of the portfolio and ranks #4455 among its holdings.

10 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • Arax Advisory Partners held 5,552 shares of VolitionRx Ltd worth $7.5K as of Q2 2026.
  • VolitionRx Ltd was a new Arax Advisory Partners position in Q2 2026.
  • VolitionRx Ltd made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4455 holding.
  • 10 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.